Evidence map›Paper›PMID 40593943›Full record

ArticleScientific data2025

Coding and non-coding RNA expression in NSC34 cells following TDP-43 depletion and mutant TDP-43 M337V expression.

Ismail Gbadamosi, Sandra Binias, Bartłomiej Gielniewski, Ramiro Magno, Isabel Duarte, Ali Jawaid

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ismail GbadamosiLaboratory for Translational Research in Neuropsychiatric Disorders (TREND), Nencki Institute of Experimental Biology, Warsaw, Poland. ismail.gbadamosi@port.lukasiewicz.gov.pl.ORCID 0000-0002-1932-7519
Sandra BiniasLaboratory of Sequencing, Nencki Institute of Experimental Biology, Warsaw, Poland.
Bartłomiej GielniewskiLaboratory of Sequencing, Nencki Institute of Experimental Biology, Warsaw, Poland.
Ramiro MagnoPattern Institute, Faro, Portugal.
Isabel DuartePattern Institute, Faro, Portugal.
Ali JawaidTranslational Neuropsychiatry Research Group, Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wroclaw, Poland. ali.jawaid@port.lukasiewicz.gov.pl.

Funding

EU Joint Programme - Neurodegenerative Disease Research (Programi i Përbashkët i BE-së për Kërkimet mbi Sëmundjet Neuro-degjeneruese) TREMENDOS; UMO-2022/04/Y/NZ5/00122
6 · The paper itself

Abstract

Several neurodegenerative disorders (NDDs), notably amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by pathological cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP-43) in neurons and glia. Primarily localized in the nucleus under physiological conditions, TDP-43 is a critical regulator of RNA processing and metabolism. Therefore, RNA changes induced by TDP-43 depletion or mutation could play an important role in the pathogenesis of ALS and other TDP-43 related NDDs.To investigate these effects in NSC34 motor neuron-like cells, a commonly used cellular model of ALS, we used RNA interference to knock down TDP-43 and overexpressed the ALS-associated TDP-43 M337V mutation. RNA from both these experiments was enriched for small and large transcripts and subsequently analyzed via next-generation sequencing.The resulting transcriptomics datasets offer a valuable resource for studying the impact of TDP-43 depletion and mutant over-expression in motor neurons. These data enable comprehensive differential expression analyses and functional enrichment studies, identifying cellular pathways affected by TDP-43 depletion or mutation. Additionally, the inclusion of non-coding RNAs facilitates the construction of gene regulatory networks, providing insights into the interplay between coding and non-coding RNAs in gene expression regulation under TDP-43 loss-of-function or pathogenic mutation conditions.

Indexed as

Amyotrophic Lateral SclerosisDNA-Binding ProteinsMotor NeuronsRNA, UntranslatedAnimalsCell LineHumansMiceMutationRNA InterferenceTranscriptomeDNA-Binding ProteinsRNA, UntranslatedTARDBP protein, human

Identifiers

PMID40593943
PMCPMC12218450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.